Number of the records: 1  

Deletion of protease-activated receptor 2 prolongs survival of scrapie-inoculated mice

  1. 1.
    0389996 - FGÚ 2013 RIV GB eng J - Journal Article
    Matěj, R. - Olejár, Tomáš - Janoušková, O. - Holada, K.
    Deletion of protease-activated receptor 2 prolongs survival of scrapie-inoculated mice.
    Journal of General Virology. Roč. 93, č. 9 (2012), s. 2057-2061. ISSN 0022-1317. E-ISSN 1465-2099
    Institutional support: RVO:67985823
    Keywords : protease-activated receptor (PAR2) * scrapie * neurodegenerative disorders
    Subject RIV: FN - Epidemiology, Contagious Diseases ; Clinical Immunology
    Impact factor: 3.127, year: 2012

    Proteinase-activated receptor 2 (PAR2) has recently been identified to be a possible modulator of neurodegeneration. To investigate whether PAR2 plays a role in prion infection, we inoculated PAR2-deficient (PAR2/) and wild-type (WT) mice intracerebrally with the Rocky Mountain Laboratory strain of scrapie. PAR2/ mice demonstrated a delayed onset of clinical symptoms, including weight loss, and demonstrated moderate but highly significant prolongation of survival over WT controls. Concomitantly, no apparent differences in brain pathology, infectivity or features of brain prion protein between deceased WT and PAR2/mice were found. Our study suggests that PAR2 deletion modulates dynamics of the disease without gross perturbation of its pathogenesis
    Permanent Link: http://hdl.handle.net/11104/0218882

     
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.